DROPLITE spun out of ICFO in December 2018 after developing for more than four years in ICFO’s KTT Launchpad in collaboration with COSINGO. Their biosensing device was fully developed in house and is a combination of advanced microfluidics, customized chemistry, a proprietary optical detection system, electronics and signal processing. The lab-on-a-chip technology allows a rapid and accurate way to test and monitor health conditions in both humans and animals mainly focused on blood samples.

Initial stages of technology development received funding from the European Union. Upon entry in ICFO’s Launch Pad, it received additional financial support from the CELLEX Foundation, the Barcelona City Council, the Castelldefels City Council.

DROPLITE emerged from an idea and collaboration between the Plasmon Nano-optics research group led by ICREA Prof. at ICFO Romain Quidant and SME COSINGO. COSINGO’s founder, Rafaël Porcar Guezenec, stayed on as DROPLITE’s CTO. André Guedes, DROPLITE’s CEO, holds a PhD degree in Physics Engineering from the University of Lisbon and joined ICFO’s KTT unit in 2017 as a business developer.